Vor Biopharma Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VOR, updated each market day.
VOR AI Sentiment
AI sees no strong directional signal for Vor Biopharma Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Vor Biopharma Inc. Common Stock
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Sector
Exchange
Market Cap
$714,150,508
Cap Tier
Employees
168
Headquarters
BOSTON, MA
Listed Since
Feb. 5, 2021
Website
VOR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VOR Volatility
Vor Biopharma Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
